You are viewing: China Pharmaceutical Quality Management Software (QMS) Market analysis

The China Pharmaceutical Quality Management Software (QMS) Market was valued at $119.1 Million in 2025 and projected to reach to $231 Million by 2030, representing a compound annual growth rate of 14.2%. China's Pharmaceutical Quality Management Software market is poised for substantial growth as regulatory frameworks become increasingly stringent and manufacturers prioritize compliance with NMPA standards.

China Pharmaceutical Quality Management Software (QMS) Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Pharmaceutical Quality Management Software (QMS) Market Trends and Insights

  • This 14.2% compound annual growth rate reflects China's accelerating regulatory compliance requirements and digital transformation across the pharmaceutical sector.
  • China's stringent Good Manufacturing Practice (GMP) standards and increasing foreign investment in local pharmaceutical manufacturing are driving widespread QMS adoption among both multinational and domestic enterprises. The market growth in China is underpinned by the country's commitment to pharmaceutical quality standards and modernization of production facilities.
  • China's pharmaceutical companies are increasingly investing in cloud-based and integrated QMS solutions to streamline operations and meet international export requirements.
  • Between 2025 and 2030, China's market expansion will be supported by government initiatives promoting industry digitalization, rising healthcare demand, and the need for real-time quality monitoring across manufacturing networks..

Key Market Statistics

  • CAGR (2025-2030) 14.2% CAGR
  • Market Size, 2025 ~USD 119.1 Million
  • Forecast, 2030 ~USD 231 Million
  • Country China

China Pharmaceutical Quality Management Software (QMS) Market Overview

Rapid Market Expansion :

China's Pharmaceutical QMS market is growing at 14.2% CAGR, outpacing the global rate of 13.3%, driven by increasing regulatory pressures and digital transformation initiatives across Chinese pharmaceutical manufacturers.

GMP Compliance Acceleration :

Stringent Good Manufacturing Practice (GMP) standards enforced by China's National Medical Products Administration (NMPA) are compelling pharmaceutical companies to adopt advanced QMS solutions for regulatory adherence and operational efficiency.

Significant Market Growth Trajectory :

The market is projected to nearly double from $119.1 million in 2025 to $231.0 million by 2030, reflecting strong investment in quality management infrastructure and digital modernization across China's pharmaceutical sector.

Digital Transformation Momentum :

Chinese pharmaceutical manufacturers are increasingly adopting cloud-based and AI-enabled QMS platforms to streamline production processes, reduce compliance risks, and enhance product quality in a highly competitive market.

China Pharmaceutical Quality Management Software (QMS) Market Dynamics

  • The 14.2% CAGR through 2030 reflects a structural shift toward digitalization, with pharmaceutical companies investing heavily in integrated QMS platforms to manage complex manufacturing processes and ensure product safety. The market expansion is further accelerated by China's position as a global pharmaceutical hub and the government's emphasis on quality-driven manufacturing.
  • As companies scale operations and pursue international certifications, demand for sophisticated QMS solutions will intensify, creating significant opportunities for vendors offering localized, compliant, and scalable software platforms tailored to China's unique regulatory environment..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • Zensar Technologies Limited
  • International Business Machines Corporation

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • China's Pharmaceutical QMS market is valued at $119.1 million in 2025 and will nearly double to $231.0 million by 2030, representing a 14.2% CAGR.
      • China's regulatory environment and GMP compliance mandates are primary drivers of QMS software adoption across pharmaceutical manufacturers.
      • Cloud-based and integrated QMS solutions are gaining traction in China as companies seek scalability and real-time quality monitoring capabilities.
      • China's pharmaceutical export growth and international quality standards alignment are accelerating investment in advanced QMS technologies through 2030.

      Pharmaceutical Quality Management Software (QMS) Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment BIOTECHNOLOGY COMPANIES (End User)
      Forecast Period 2025–2030
      Growth Rate CAGR of 13.3% from 2025 to 2030
      Largest Segment LARGE ENTERPRISES (Enterprise Size)
      Market Size Base Year (Billions) ~USD 1.6 (2025)
      Revenue Forecast (Billions) ~USD 2.98 (2030)
      Segments Covered Process, Application, Enterprise Size, End User, End User 2023–2030

      China Pharmaceutical Quality Management Software (QMS) Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Process

      • Clinical Trials
      • Commercialization, Marketing, & Sales
      • Commercialization, Marketing, And Sales
      • Distribution & Supply Chain
      • Manufacturing/ Production
      • Other Processes
      • Post-Market Surveillance
      • Quality Assurance/ Quality Control
      • Quality Assurance/Quality Control
      • Regulatory Compliance

      By Application

      • Audit & Inspection Management
      • Capa (Corrective & Preventive Action) Management
      • Change Control Management
      • Document Control & Esop
      • Other Applications
      • Regulatory & Compliance Management
      • Risk Management
      • Supplier Quality Management
      • Training Management

      By Enterprise Size

      • Large Enterprises
      • Small & Medium Enterprises

      By End User

      • Biotechnology Companies
      • Contract Development & Manufacturing Organizations (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmos)
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organization (Cro)
      • Contract Research Organizations (Cro)
      • Contract Research Organizations (Cros)
      • Other End Users
      • Pharmaceutical Companies

      By End User 2023–2030

      • Biotechnology Companies
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organizations (Cro)
      • Other End Users
      • Pharmaceutical Companies

      CHINA: PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BIOTECHNOLOGY COMPANIES1921.724.828.432.637.44349.614.8
      CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMO)1415.817.920.32326.129.733.913.6
      CONTRACT RESEARCH ORGANIZATIONS (CRO)14.416.318.420.923.72730.835.213.8
      OTHER END USERS5.96.67.48.39.310.411.713.212.3
      PHARMACEUTICAL COMPANIES39.244.550.657.765.975.486.499.214.4
      TOTAL92.6104.9119.1135.5154.5176.4201.723114.2

      Target Audience

      • Pharmaceutical Manufacturers : Chinese and multinational pharma companies operating in China need this data to benchmark their QMS investments, understand compliance requirements, and identify best-in-class software solutions for manufacturing excellence.
      • QMS Software Vendors : Software providers targeting China's pharmaceutical sector require market sizing, growth forecasts, and regulatory insights to develop localized products, refine pricing strategies, and prioritize market entry or expansion initiatives.
      • Private Equity & Investors : Investment firms evaluating opportunities in China's healthcare technology sector use this market intelligence to assess portfolio company potential, identify acquisition targets, and make informed capital allocation decisions.
      • Regulatory & Compliance Consultants : Consultants advising pharmaceutical companies on NMPA compliance and quality management strategies leverage market data to demonstrate ROI of QMS implementations and guide clients through digital transformation initiatives.
      • Healthcare Technology Analysts : Industry analysts, research firms, and market intelligence providers use China-specific QMS market data to support client advisory services, competitive benchmarking, and strategic planning across the pharmaceutical sector.

      Key Companies in the China Pharmaceutical Quality Management Software (QMS) Market

      CompanyHQOwnershipStrongest segments
      HONEYWELL INTERNATIONAL INC.United StatesPublic CompanyIndustrial Automation (control, instrumentation, smart energy, sensing, PPE, software and analytics),Building Automation (building control software, energy management, security, fire, services),Energy and Sustainability Solutions / UOP (licensed process technologies, equipment, catalysts, software),
      IQVIAUnited StatesPublic CompanyTechnology & Analytics Solutions,Research & Development Solutions,Contract Sales & Medical Solutions,
      VEEVA SYSTEMS INC.United StatesPublic CompanyVeeva Commercial Cloud (Vault CRM, Medical, PromoMats, Crossix, CRM Pulse),Veeva Development Cloud (Clinical Platform, Clinical Data Management, Safety, RIM),Veeva Quality Cloud,
      DASSAULT SYSTèMESFrancePublic Company3D Modeling (CATIA, SOLIDWORKS, GEOVIA, BIOVIA),PLM & Collaboration (ENOVIA, CENTRIC PLM, 3DEXCITE, 3DEXPERIENCE platform),Simulation & Manufacturing (SIMULIA, DELMIA, 3DVIA),
      HEXAGON ABSwedenPublic CompanyManufacturing Intelligence (metrology, CAD/CAM, CAE, quality software),Geosystems (surveying, mapping, laser scanning, AEC solutions),Autonomous Solutions and Positioning (GNSS, anti-jam, machine control, autonomy),
      IDEAGENUnited KingdomPrivate CompanyRegulatory Compliance & GRC Platforms,Operational Performance & Quality Management,Workplace Health & Safety (incl. Reactec),
      SOFTEXPERTBrazilPrivate CompanyBusiness Process & Corporate Performance Management,Enterprise Quality, Risk & GRC,Enterprise Content & Asset Management,
      INSTEMUnited KingdomPrivate CompanyResearch study management software (discovery, preclinical, early clinical),Regulatory submission solutions (SEND generation, conversion, validation),In silico and data insights solutions,
      INTELLECT, INCIndiaPublic CompanyWholesale & Corporate Banking (lending, payments, liquidity, trade, treasury),Consumer Banking (core, lending, cards, digital engagement),Wealth, Capital Markets, and Insurance Platforms,

      HONEYWELL INTERNATIONAL INC.

      Honeywell International Inc. is a diversified technology and manufacturing company founded in 1885 and headquartered in the United States. With 101,000 employees, the publicly traded company operates across multiple industrial sectors including aerospace, building technologies, and performance materials.

      IQVIA

      IQVIA is a United States-based public company with 93,000 employees that provides integrated information and technology solutions to the life sciences industry.

      VEEVA SYSTEMS INC.

      Veeva Systems Inc. is a United States public company founded in 2007 with 7,928 employees that provides cloud-based software solutions for the life sciences industry.

      DASSAULT SYSTèMES

      Dassault Systèmes is a French public company founded in 1981 with 25,724 employees that provides 3D design, digital mock-up, and product lifecycle management software solutions.

      HEXAGON AB

      Hexagon AB is a Swedish public company founded in 1975 with 16,118 employees that provides digital solutions and software for industrial and geospatial applications.

      IDEAGEN

      Ideagen is a United Kingdom-based private company founded in 1993 with 697 employees that develops software solutions for quality, risk, and compliance management.

      SOFTEXPERT

      SoftExpert is a Brazil-based private company founded in 1995 with 170 employees that provides software solutions for process management, quality, and compliance.

      INSTEM

      Instem is a United Kingdom-based private company founded in 1969 with 510 employees that provides software and services for the life sciences and pharmaceutical industries.

      INTELLECT, INC

      Intellect, Inc. is an India-based public company founded in 2011 with 6,876 employees that provides software and IT solutions for various industries.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Quantified market data showing China's QMS market growing from $119.1M to $231M (2025-2030) validates investment decisions and helps stakeholders understand the scale of opportunity in this high-growth segment.
      • Regulatory Landscape Intelligence : Detailed insights into China's NMPA GMP requirements and compliance drivers enable vendors and manufacturers to align product development and go-to-market strategies with local regulatory expectations.
      • Competitive Positioning Strategy : China-specific market analysis reveals growth drivers, adoption trends, and competitive dynamics, allowing vendors to identify market gaps and develop targeted solutions for Chinese pharmaceutical manufacturers.
      • Investment & Expansion Planning : Comprehensive market forecasts and growth trajectories support strategic planning for pharmaceutical companies, software vendors, and investors evaluating expansion or partnership opportunities in China's QMS sector.
      • Digital Transformation Roadmap : Insights into China's accelerating digital transformation in pharma manufacturing help stakeholders prioritize technology investments and understand the evolving competitive landscape for QMS solutions.

      Frequently asked questions

      What is the current size of China's Pharmaceutical QMS market?

      China's Pharmaceutical Quality Management Software market is valued at $119.1 million in 2025 and is projected to grow to $231.0 million by 2030.

      What is the growth rate of China's Pharmaceutical QMS market?

      China's Pharmaceutical QMS market is growing at a compound annual growth rate (CAGR) of 14.2% from 2025 to 2030.

      What factors are driving growth in China's Pharmaceutical QMS market?

      Key drivers include China's stringent GMP compliance requirements, digital transformation initiatives, pharmaceutical export growth, and the need for real-time quality monitoring in manufacturing operations.

      Which types of QMS solutions are most popular in China?

      Cloud-based and integrated QMS solutions are increasingly popular in China as pharmaceutical companies seek scalability, real-time monitoring, and compliance with international quality standards.

      How does China's market compare to the global Pharmaceutical QMS market?

      China's 14.2% CAGR outpaces the global market growth rate of 13.3%, reflecting accelerated digital adoption and regulatory compliance investments specific to the Chinese pharmaceutical sector.

      RESEARCH METHODOLOGY

      The study involved several key activities to estimate the current size of the pharmaceutical quality management software (QMS) market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the pharmaceutical quality management softwarecare market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing pharmaceutical quality management software care solutions is assessed using secondary data from both paid and free sources. This involves analysing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

      Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pharmaceutical quality management software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

      Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

      After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyse industry trends, evaluate the competitive landscape of pharmaceutical quality management software care offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Pharmaceutical Quality Management Software Market
 Size, and Share

      Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by process, application, enterprise size, end users, and region).

      Pharmaceutical Quality Management Software Market: Top-Down and Bottom-Up Approach

      Pharmaceutical Quality Management Software Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pharmaceutical quality management software market.

      Market Definition

      Pharmaceutical quality management software is a formalized, electronic system designed to document, automate, and manage all processes, procedures, and responsibilities associated with ensuring the quality and regulatory compliance of pharmaceutical products throughout their lifecycle. It serves as a centralized platform for managing critical quality activities including document control, SOPs, CAPA, audits, training, risk management, and supplier quality to ensure product safety, efficacy, and regulatory compliance..

      Key Stakeholders

      • Pharmaceutical companies
      • Pharmaceutical quality management software Providers
      • Biotechnology firms
      • Academic Research Institutes
      • Contract Manufacturing Organizations
      • Contract Research Organizations
      • Market Research and Consulting Firms
      • Regulatory Authorities / Agencies
      • Quality Assurance & Quality Control Departments
      • Research & Development (R&D) Teams
      • Third-party Auditors / Inspections Bodies
      • Suppliers / Raw Material Vendors

      Report Objectives

      • To define, describe, and forecast the global pharmaceutical quality management software market based on process, application, enterprise size, end users, and region.
      • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical quality management software market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the pharmaceutical quality management software market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
      • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the pharmaceutical quality management software market
      • To benchmark players within the pharmaceutical quality management software market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe Pharmaceutical quality management software Market into Denmark, Norway, and others
      • Further breakdown of the Rest of Asia Pacific Pharmaceutical quality management software Market into Vietnam, Pakistan, New Zealand, and others
      • Further breakdown of the Rest of Latin America Pharmaceutical quality management software Market into Argentina, Chile, Colombia, and others
      • Further breakdown of the Rest of Middle East & Africa Pharmaceutical quality management software Market into Egypt, Nigeria, Israel, and others

      Get the Full Pharmaceutical Quality Management Software (QMS) Market Report

      Full forecast, segment splits, and company analysis for all Pharmaceutical Quality Management Software (QMS) Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status